Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44,666,667
-
Number of holders
-
63
-
Total 13F shares, excl. options
-
18,909,639
-
Shares change
-
-6,669,672
-
Total reported value, excl. options
-
$8,390,056
-
Value change
-
-$3,556,213
-
Put/Call ratio
-
22%
-
Number of buys
-
32
-
Number of sells
-
62
-
Price
-
$0.4438
Institutional Holders of HARVARD BIOSCIENCE INC - Common Stock (HBIO) as of Q2 2025
As of 30 Jun 2025 HARVARD BIOSCIENCE INC - Common Stock (HBIO) had 105 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 18,909,639 shares of stock of the company.
Largest 10 holders included AMH Equity Ltd, Harvey Partners, LLC, VANGUARD GROUP INC, Granahan Investment Management, LLC, DIMENSIONAL FUND ADVISORS LP, BlackRock, Inc., ACADIAN ASSET MANAGEMENT LLC, Meros Investment Management, LP, UBS Group AG, and RENAISSANCE TECHNOLOGIES LLC.
This table shows 105 institutional shareholders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.